Overview

Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora

Status:
Completed

Trial end date:
2007-06-01

Target enrollment:
0

Participant gender:
All

Summary

Topical Treatment of Bacterial Conjunctivitis and its Effect on Microbial Flora

Phase:

Phase 4

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Alcon Research

Collaborator:

Tufts University

Treatments:

Moxifloxacin
Norgestimate, ethinyl estradiol drug combination

Criteria

Inclusion Criteria:

- Patients from 1 to 13 years of age that have diagnosis of bacterial conjunctivitis in
either or both eyes (for < 3 days duration) based on clinical observation; matched
healthy controls

Exclusion Criteria:

- Cannot have had bacterial conjunctivitis symptoms as reported by parent for > 2 days